Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) fair value: what the stock is really worth
As of Nov 10, 2026: fair value (intrinsic value) of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi stock TRY 23.24, price TRY 20.90, upside +11.2%, quality 53 out of 100. Rating: undervalued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 6, 2026.
How to read this chart
60‑month range 2.71 TRY – 42.66 TRY · fair‑value band 17.36 TRY – 33.30 TRY · the 20.90 TRY price screens below the 23.24 TRY fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 6, 2026.
Follow Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi in your weekly email
Every Wednesday you see whether Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi operates in the construction chemicals sector in Turkey and internationally. It operates through the Construction Chemicals; and Concrete, Cement Chemicals, and Raw Materials segments.
Show moreShow less
Its product portfolio includes waterproofing products, such as cement -based, acrylic-based, bitumen-based, polyurethane-based, and membrane-based waterproofing products, as well as impregnated primers and waterproofing bands; tile adhesives, including cement, acrylic, and resin-based adhesives, as well as cement, epoxy, and resin-based grouts; and surface cleaning and maintenance products, sealants, and tile levelling systems.
It also provides cement and epoxy-based repair mortars, cement and epoxy-based grout mortars, primers and additives, and cement-based smoothing screeds for technical applications; primers and coverings, industrial coverings, cement-based hardeners, surface hardeners, and curing materials for floor applications; decorative products, interior paints, exterior paints and plasters, surface preparation materials, and coloring systems for paints and decorative applications; and system components, adhesives and plasters, decorative coatings, and complementary accessories for thermal insulation applications.
In addition, it offers bathroom, kitchen, pool, balcony and terrace, basement and foundation, floor, interior, and facade solutions; and assembly and sealing products. The company was incorporated in 1973 and is headquartered in Istanbul, Turkey.
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi operates as a subsidiary of H. Ibrahim Bodur Holding Anonim Sirketi.
Stock analysis
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) currently trades at 20.90 TRY, while our model-based Fair Value estimate is 23.24 TRY, implying the stock looks roughly 10% undervalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of 74.02 TRY per share, and 22 of the 26 models we run sit above the 20.90 TRY price.
Bear case: the Dividend Discount group reads lowest at 3.88 TRY, and 4 of the 26 models stay below the price. Data coverage for this calculation is low.
Scenario range: 17.36 TRY (bear) to 33.30 TRY (bull), the price of 20.90 TRY sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 53/100 (solid quality), in the Basic Materials sector.
Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi reported revenue of 10.7B TRY in FY2025 versus 810M TRY in FY2021, a compound +90.6%/yr. Reported net income was 1.1B TRY in FY2025, compounding +51.9%/yr from FY2021.
Key figures
Market cap 9.6B TRY (≈ $191M) Micro · P/E ratio 942.0 · EPS (TTM) 0.0200 TRY · Dividend yield 3.1% · Net margin 10.6% · Return on equity 9.9% · Return on assets (EBIT) 21.2% (5-year average) · Operating margin 15.6%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 55 out of 100 (low confidence).
What moves the price
The share trades about 51% below its 52-week high and 16% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −41% fair-value upside, at 11%, KLKIM screens cheaper than that median.
Fair Value models
Bear17.36 TRYFair Value 23.24 TRYBull33.30 TRY
Price 20.90 TRY · Upside +11.2%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
FCF DCF36.40 TRY45.36 TRY70.75 TRY80
Growth DCF34.61 TRY46.33 TRY66.38 TRY79
Residual Income11.80 TRY13.47 TRY17.60 TRY76
All 26 models by family
DCF Models
FCF DCF36.40 TRY45.36 TRY70.75 TRY80
Owner Earnings24.04 TRY37.76 TRY59.02 TRY75
5Y Revenue Exit33.31 TRY49.62 TRY83.44 TRY71
5Y EBITDA Exit41.19 TRY65.48 TRY112.95 TRY73
5Y P/E Exit36.14 TRY66.86 TRY107.54 TRY69
10Y Revenue Exit33.67 TRY56.84 TRY69.05 TRY67
10Y EBITDA Exit38.24 TRY68.61 TRY119.07 TRY66
10Y P/E Exit35.66 TRY61.06 TRY100.29 TRY62
Earnings-Based
Graham-Dodd16.80 TRY117.18 TRY164.44 TRY63
Lynch FV43.73 TRY62.47 TRY81.21 TRY61
PEG = 1.043.73 TRY62.47 TRY81.21 TRY57
EPV28.42 TRY30.41 TRY31.95 TRY74
Dividend Discount
Gordon GGM2.65 TRY3.86 TRY4.56 TRY69
DDM Multi-Stage2.65 TRY3.90 TRY4.19 TRY67
Multiples
P/E Multiple31.50 TRY42.01 TRY52.51 TRY63
P/S Multiple26.16 TRY34.88 TRY43.60 TRY58
P/B Multiple30.00 TRY40.00 TRY50.00 TRY55
EV/EBIT49.53 TRY66.08 TRY82.63 TRY66
EV/EBITDA40.95 TRY54.64 TRY68.33 TRY67
EV/Revenue24.31 TRY34.77 TRY45.24 TRY53
Asset-Based
NCAV (Graham)3.42 TRY5.18 TRY6.47 TRY55
Growth DCF
Growth DCF34.61 TRY46.33 TRY66.38 TRY79
Rev-Margin DCF33.40 TRY55.90 TRY97.81 TRY70
Economic Profit
Residual Income11.80 TRY13.47 TRY17.60 TRY76
ROIC Compounder31.54 TRY37.14 TRY43.46 TRY72
Growth Earnings
Growth-Adj P/E51.82 TRY74.02 TRY96.23 TRY67
The fair value above starts from this blend and is adjusted for a cyclical peak year.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.90/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+9.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+70.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+82.6%
Start year 2020 (pandemic)
Revenue growth 7 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+63.2%
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years), in TRY ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TRY: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+30.7%
Earnings growth per share plus dividend.
Earnings per share, growth per year+27.6%
Dividend (yield on the price)3.1%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.17% → 20%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+1.0%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Turkey: IMF forecast 19.3% a year to 2030, 28.5% from 2016 to 2025) that is about −15.4% a year for the price.
Compare Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 758 stocks
Beats the industry median on 7/9 measures
Overall it ranks above its industry peers.
Valuation
Quality Score53 · Above median
Fair Value upside+11.2% · Top 25%
Profitability
Return on equity (12 months)9.9% · Above median
Return on assets11.5% · Top 25%
Net margin (12 months)6.0% · Above median
Operating margin (12 months)15.6% · Top 25%
Growth and dividend
Revenue growth (quarter YoY)−5.5% · Bottom 25%
Dividend yield (12 months)3.1% · Top 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi Fair Value". https://www.fairvalue-calculator.com/stock/KLKIM
Frequently asked questions
Is Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) overvalued or undervalued?
As of Nov 6, 2026, our model estimates a fair value of 23.24 TRY versus a price of 20.90 TRY, about +11% upside (undervalued).
What is the fair value of KLKIM?
Our model-based fair value for Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 23.24 TRY (as of Nov 6, 2026), built from audited fundamentals. The current price: 20.90 TRY.
What is the quality score of KLKIM?
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi has a Quality Score of 53/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Our model-based price target is the fair value of 23.24 TRY (as of Nov 6, 2026) from 26 valuation models. Cautious scenario 17.36 TRY, optimistic scenario 33.30 TRY. It is a calculation from audited fundamentals, not an analyst target.
What is the Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi stock forecast for 2026?
Our models put fair value at 23.24 TRY, about +11% upside versus a price of 20.90 TRY (undervalued). Cautious scenario 17.36 TRY, optimistic scenario 33.30 TRY. The calculation is refreshed regularly with new filings.
What is the revenue of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi reported trailing-twelve-month revenue of about 10.3B TRY (latest available figure, as of Nov 6, 2026).
Does Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi pay a dividend?
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi currently shows a dividend yield of 3.12% relative to its recent price (as of Nov 6, 2026).
How much is the dividend of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) and when is the ex-dividend date?
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi pays a dividend of 0.652 TRY per share a year, a dividend yield of 3.1%. The last ex-dividend date was May 8, 2026. A dividend has been paid every year since at least 2022. Free cash flow covers the dividend 3.79 times. Our assessment: Sustainable. Payout and cash coverage both look sustainable.
What growth is priced into Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
For today's price to be fair in a discounted-cash-flow model, Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi would have to grow free cash flow by +1.0 % per year for five years (discount rate 17.2 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +82.7 % per year. As of Nov 6, 2026.
What discount rate (WACC) does the fair value of KLKIM use?
Our models discount Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi at 17.2 %: a base by market capitalisation (micro), country premium for Turkey. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi that is +1.0 % per year for five years, then slowing evenly to 2 % by year ten, using the same discount rate (17.2 %) and the same formula as our fair value.
How much growth has Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) delivered so far?
Over the past 5 years revenue at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi grew +82.7 % a year. The price currently implies free-cash-flow growth of +1.0 % per year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) growing?
The median revenue growth in the sector is +8.7 % a year. That is the yardstick for the growth priced into Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (+1.0 % per year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The free-cash-flow yield on the price is 11.81 %: that much free cash flow Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi produces per unit of market value. When it exceeds the discount rate of our models (17.2 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi it is 23.24 TRY per share (as of Nov 6, 2026), against a price of 20.90 TRY. It is the blended result of 26 valuation models in 8 families (DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings).
Is Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi stock overvalued or undervalued in 2026?
As of Nov 6, 2026, KLKIM trades below its calculated fair value: price 20.90 TRY, fair value 23.24 TRY, a gap of about +11% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of KLKIM?
No. The price is what the market pays today (20.90 TRY); the fair value is what the company's own numbers justify (23.24 TRY). For Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi the two are 2.34 TRY per share apart. That gap is exactly why we show both numbers side by side.
How much is Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi worth?
The market values Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi at about 9.6B TRY (market capitalisation, as of Nov 6, 2026). Per share that is 20.90 TRY; our models calculate a fair value of 23.24 TRY per share.
What do the bullish and bearish scenarios say about KLKIM?
Our models span a range for Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi: cautious scenario 17.36 TRY, base 23.24 TRY, optimistic 33.30 TRY per share (as of Nov 6, 2026, price 20.90 TRY). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Balance-sheet figures for Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (as of Nov 6, 2026): return on equity 9.9%. They feed the Quality Score of 53/100, which measures business quality independently of the share price.
How far is KLKIM from its 52-week high?
Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi trades at 20.90 TRY, about 51% below its 52-week high of 42.66 TRY and 16% above the low of 17.94 TRY (as of Nov 10, 2026). Distance from the high says nothing about value: that is what the fair value of 23.24 TRY is for.
Which stocks are comparable to Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi?
From the same area (Basic Materials) we also value Linde plc, Ecolab Inc, The Sherwin-Williams Company, Nan Ya Plastics Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi stock attractive at the current price?
The data as of Nov 6, 2026: price 20.90 TRY, calculated fair value 23.24 TRY (+11%), Quality Score 53/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of KLKIM calculated?
We run Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi through 26 models from 8 families: DCF Models, Earnings-Based, Dividend Discount, Multiples, Asset-Based, Growth DCF, Economic Profit, Growth Earnings. Every model gets the same audited fundamentals; the fair value of 23.24 TRY builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi currently trades 10% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The closing price on Nov 10, 2026 was 20.90 TRY. Our model-based fair value is 23.24 TRY, about +11% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi right now?
A fairly wide model range (17.36 TRY to 33.30 TRY) leaves room in how you read the outcome. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi
How large is the market capitalisation of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The market capitalisation of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 9.6B TRY (≈ $191M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/E ratio of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The price-to-earnings ratio of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 942.0 (as of Oct 27, 2026). Price to earnings: how many years of current profit you pay for the stock. A P/E of 10 means ten years of profit.
What are the earnings per share of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Earnings per share at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi are 0.0200 TRY (price ÷ EPS = P/E 942.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The dividend yield of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 3.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The net margin of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 10.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The return on equity (ROE) of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 9.9% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
On an EBIT basis the return on assets of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 21.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
The operating margin of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 15.6% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Revenue at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is growing −5.5% versus a year earlier (3y avg +70.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM)?
Earnings per share at Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi are growing −90.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi (KLKIM) carry?
The net debt of Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi is 49.2M TRY (fiscal year 2018, ≈ 0.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Why does Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi meet the fair value rule although the fair value shown is lower?
Peak profit dampened: 46.33 TRY → 23.24 TRY. The latest annual profit is far above the years before, and such peaks rarely last. So we calculate cautiously with 23.24 TRY instead of 46.33 TRY. If the profit stays high, we ease the caution year by year. As in the backtest, the fair value rule checks the value before: +122% against the price.
Free · no account needed
Watch Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi in the live analysis
One click puts Kalekim Kimyevi Maddeler Sanayi Ve Ticaret Anonim Sirketi on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Thin data
Nov 6, 2026